Study start-up is a critical component of the end-to-end trial process, yet many clinical operations teams still rely on manual trackers and stand-alone disconnected technology to manage and monitor site selection, activation and greenlight progress.
View this webinar to hear GSK share insights about their journey to faster study start-up – from drivers for change to the technology evaluation process and how a unified clinical operating environment improves trial execution of critical start-up business processes.